SCHEMBL377548

SCHEMBL377548

O=c1sc2cccc3c2n1CCC3

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.47
ALDH1A1 P00352 3/20 0.47
HSD17B10 Q99714 2/20 0.47
USP2 O75604 2/20 0.47
MCL1 Q07820 2/20 0.44
KDM4E B2RXH2 5/20 0.42
LMNA P02545 2/20 0.42
CYP1A2 P05177 1/20 0.42
KMT2A Q03164 2/20 0.41
POLB P06746 1/20 0.41
GAA P10253 2/20 0.39
MEN1 O00255 1/20 0.39
HTR2A P28223 2/20 0.38
HTR2C P28335 1/20 0.38
CES1 P23141 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CDK4 P11802 1/20 0.36
CCND1 P24385 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HTR1A P08908 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3469727 0.80 HPGD (0.43) HPGDALDH1A1HSD17B10USP2MCL1
SCHEMBL11105965 0.80 MCL1 (0.41) HPGDALDH1A1HSD17B10USP2MCL1
SCHEMBL8986755 0.71 HTR1A (0.36) KMT2AMEN1HTR1ADRD2
SCHEMBL11207376 0.68 HPGD (0.55) HPGDALDH1A1HSD17B10USP2MCL1
SCHEMBL4850347 0.68 HTR1A (0.55) HPGDALDH1A1HSD17B10USP2CDK4
SCHEMBL4850625 0.66 HSD17B10 (0.49) HPGDALDH1A1HSD17B10USP2MCL1
SCHEMBL7345010 0.66 HSD17B10 (0.46) HPGDALDH1A1HSD17B10USP2MCL1
SCHEMBL12000241 0.65 MCL1 (0.55) HPGDALDH1A1HSD17B10USP2MCL1
SCHEMBL7005388 0.65 HPGD (0.55) HPGDALDH1A1HSD17B10USP2MCL1
SCHEMBL10675886 0.65 ALDH1A1 (0.55) HPGDALDH1A1HSD17B10USP2MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408863-B1 NUCLEIC ACID BINDING DYES AND USES THEREFOR PROMEGA CORP (US) 2018-01-10 EP disclosed
US-9458499-B2 Nucleic acid binding dyes and uses therefor PROMEGA CORPORATION (US) 2016-10-04 US disclosed
US-9458499-B2 Nucleic acid binding dyes and uses therefor PROMEGA CORPORATION (US) 2016-10-04 US disclosed
US-9458499-B2 Nucleic acid binding dyes and uses therefor PROMEGA CORPORATION (US) 2016-10-04 US disclosed
US-20160083782-A1 NUCLEIC ACID BINDING DYES AND USES THEREFOR JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT 2016-03-24 US disclosed
US-20160083782-A1 NUCLEIC ACID BINDING DYES AND USES THEREFOR JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT 2016-03-24 US disclosed
US-20160083782-A1 NUCLEIC ACID BINDING DYES AND USES THEREFOR JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT 2016-03-24 US disclosed
US-9206474-B2 Nucleic acid binding dyes and uses therefor PROMEGA CORPORATION (US) 2015-12-08 US disclosed
US-9206474-B2 Nucleic acid binding dyes and uses therefor PROMEGA CORPORATION (US) 2015-12-08 US disclosed
US-9206474-B2 Nucleic acid binding dyes and uses therefor PROMEGA CORPORATION (US) 2015-12-08 US disclosed
US-8598198-B2 Nucleic acid binding dyes and uses therefor PROMEGA CORPORATION (US) 2013-12-03 US disclosed
EP-2408863-A2 NUCLEIC ACID BINDING DYES AND USES THEREFOR Promega Corporation (US) 2012-01-25 EP disclosed
WO-2010107816-A2 NUCLEIC ACID BINDING DYES AND USES THEREFOR PROMEGA CORPORATION (US) 2010-09-23 WO disclosed
WO-2010107816-A2 NUCLEIC ACID BINDING DYES AND USES THEREFOR PROMEGA CORPORATION (US) 2010-09-23 WO disclosed
US-20100233710-A1 NUCLEIC ACID BINDING DYES AND USES THEREFOR JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT 2010-09-16 US disclosed
US-20100233710-A1 NUCLEIC ACID BINDING DYES AND USES THEREFOR JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT 2010-09-16 US disclosed
US-20100233710-A1 NUCLEIC ACID BINDING DYES AND USES THEREFOR JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT 2010-09-16 US disclosed
EP-0040398-B1 PROCESS FOR PREPARING 3-SUBSTITUTED 2(3H)-BENZOTHIAZOLONES OR 2(3H)-NAPHTHOTHIAZOLONES HOECHST AKTIENGESELLSCHAFT (DE) 1985-01-16 EP disclosed
US-4429134-A FROM CORRESPONDING IMINOBENZOTHIAZOLINES HOECHST AKTIENGESELLSCHAFT (DE) 1984-01-31 US disclosed
EP-0040398-A2 Process for preparing 3-substituted 2(3H)-benzothiazolones or 2(3H)-naphthothiazolones HOECHST AKTIENGESELLSCHAFT (DE) 1981-11-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100233710-A1 NUCLEIC ACID BINDING DYES AND USES THEREFOR POLRMT, POLB, POLL HPGD 2883/4885ALDH1A1 898/4885HSD17B10 1753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.